Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies—An Interim Report
There is increasing evidence for an autoimmune aetiology in post-infectious Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). SARS-CoV-2 has now become the main trigger for ME/CFS. We have already conducted two small proof-of-concept studies on IgG depletion by immunoadsorption (IA) in po...
Main Authors: | Elisa Stein, Cornelia Heindrich, Kirsten Wittke, Claudia Kedor, Laura Kim, Helma Freitag, Anne Krüger, Markus Tölle, Carmen Scheibenbogen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-10-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/19/6428 |
Similar Items
-
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption
by: Markus Tölle, et al.
Published: (2020-07-01) -
Immunoadsorption for Treatment of Patients with Suspected Alzheimer Dementia and Agonistic Autoantibodies against Alpha1a-Adrenoceptor—Rationale and Design of the IMAD Pilot Study
by: Sylvia Stracke, et al.
Published: (2020-06-01) -
Plasma Exchange or Immunoadsorption in Demyelinating Diseases: A Meta-Analysis
by: Mark Lipphardt, et al.
Published: (2020-05-01) -
β<sub>1</sub> Adrenergic Receptor Autoantibodies and IgG Subclasses: Current Status and Unsolved Issues
by: Akane Kawai, et al.
Published: (2023-09-01) -
IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS)
by: Hannah Preßler, et al.
Published: (2024-03-01)